AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
EN
Login
EN
Surge Analysis
/
Zentalis Pharmaceuticals, Inc.
/
2026-04-09
▲ SURGE
Zentalis Pharmaceuticals, Inc.
+60.1%
ZNTL
NASDAQ
Healthcare
2026-04-09
4.42
Close
2.76
Prev Close
+60.14%
Change
19.0x
Vol Ratio
Why It Surged
2026년 3월 27일 H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 등급을 재확인하고 목표 주가를 10달러로 유지했습니다.
·
2026년 3월 27일 H.C. Wainwright는 Zentalis Pharmaceuticals(ZNTL)에 대한 주식 등급을 재확인하고 목표 주가를 10달러로 유지했습니다.
Related News
Zenas BioPharma Prices $300M Concurrent Offerings Of $200M 2.50% Convertible Senior Notes Due 2032 And 5M Shares At $20 To Fund Obexelimab Launch - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga
2026-03-27
Zoetis Inc (ZTS) Stock Price Down 3.29% on Mar 18
Gurufocus
2026-03-18
H.C. Wainwright reiterates Zentalis stock rating, $10 target By Investing
Au.Investing
2026-03-27
HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target - Zenas BioPharma (NASDAQ:ZBIO)
Benzinga
2026-03-17
Nektar stock up on trial data for eczema drug (NKTR:NASDAQ)
Seekingalpha
2026-02-10
Technical Analysis
Signals
BB Upper Break
Overbought
MACD Bullish
Above SMA20
Key Indicators
77.86
RSI (14)
2.66
SMA 20
1.75
Bollinger Lower
3.57
Bollinger Upper
2.66
Bollinger Mid
0.16
MACD
0.03
MACD Signal
0.14
MACD Hist
View Company
Back to Surge Stocks
Zentalis Pharmaceuticals, Inc. Surged +60.1% on 2026-04-09 — Analysis | Alpha Lenz